Nonhematopoietic MicroRNA-26b <sup>−/−</sup> Augments Atherosclerosis Development by Increasing Endothelial Inflammation and Leukocyte Adhesion—Brief Report
Our findings highlight that nonhematopoietic miR-26b plays a protective role in atherosclerosis by modulating endothelial cell function, suggesting potential therapeutic applications for miR-26b mimics in cardiovascular disease management.
Authors
- Linsey J. F. Peters (ORCID: https://orcid.org/0009-0009-3657-9441)
- Erik A.L. Biessen (ORCID: https://orcid.org/0000-0002-6454-8548)
- Alexander Jans (ORCID: https://orcid.org/0000-0002-2622-4278)
- Emiel P. C. van der Vorst (ORCID: https://orcid.org/0000-0001-5771-6278)
- Markus Haberbosch
- Kiril Bidzhekov
- Cheng Lin (ORCID: https://orcid.org/0009-0007-2326-1536)
- Remco T. A. Megens (ORCID: https://orcid.org/0000-0001-9871-6696)
- Matthias Bartneck (ORCID: https://orcid.org/0000-0003-1516-9610)
- C. Weber
- Yvonne Jansen (ORCID: https://orcid.org/0000-0002-1283-8260)
- H. Jin
- Yvonne Döring
Institutions
- University of Bern (CH)
- Bern University of Applied Sciences (CH)
- Maastricht University Medical Centre (NL)
- University Hospital of Bern (CH)
- Tianjin Medical University General Hospital (CN)
- Maastricht University (NL)
- DWI – Leibniz Institute for Interactive Materials (DE)
- Munich Cluster for Systems Neurology (DE)
- Universitätsklinikum Aachen (DE)
- German Centre for Cardiovascular Research (DE)
- Ludwig-Maximilians-Universität München (DE)
- RWTH Aachen University (DE)
Publication Details
- Journal
- Arteriosclerosis Thrombosis and Vascular Biology
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1161/atvbaha.125.323888
- Primary Topic
- MicroRNA in disease regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00